AU Patent

AU2021244695A1 — Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same

Assigned to PLX Opco Inc · Expires 2022-11-10 · 4y expired

What this patent protects

Disclosed herein are novel drug carriers including a non-aqueous pH dependent release system and a non-aqueous pH dependent reassembly/assembly and reabsorption/absorption system. The carriers are capable of pH dependent release of biologically active agents and assembly or reass…

USPTO Abstract

Disclosed herein are novel drug carriers including a non-aqueous pH dependent release system and a non-aqueous pH dependent reassembly/assembly and reabsorption/absorption system. The carriers are capable of pH dependent release of biologically active agents and assembly or reassembly when the carrier transitions from a low pH environment, to a high pH environment and back to a low pH environment.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021244695A1
Jurisdiction
AU
Classification
—
Expires
2022-11-10
Drug substance claim
No
Drug product claim
No
Assignee
PLX Opco Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.